BBIO vs MS · rev $221.9M vs P/E 20, $344.27B cap
BridgeBio Pharma Inc (BBIO) versus Morgan Stanley (MS) — a side-by-side from cached financials, not a winner call.
BridgeBio Pharma Inc (BBIO) is a biotechnology company listed on US.
Morgan Stanley (MS) is a capital markets company listed on US. It is led by Ted Pick.
Latest reported BBIO revenue for 2024-12-31 was $221.9M. Net income was -$543.3M. Revenue was up 2285.3% from 2023-12-31 to 2024-12-31. BBIO currently screens at market cap $13.24B.
MS does not have a complete income-statement cache yet.
BBIO currently screens at market cap $13.24B. MS currently screens at market cap $344.27B and trailing P/E 19.8.
Not investment advice. Open the BBIO and MS stock pages for the full models.
Not investment advice.